WST - West Pharmaceutical Services, Inc.
NYSE - Nasdaq Real-time price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 26.83B |
| Enterprise value | 26.25B |
| Trailing P/E | 49.55 |
| Forward P/E | 46.30 |
| PEG ratio (5-yr expected) | 8.84 |
| Price/sales (ttm) | 9.49 |
| Price/book (mrq) | 9.66 |
| Enterprise value/revenue | 9.09 |
| Enterprise value/EBITDA | 32.48 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.09 |
| 52-week change 3 | 9.00% |
| S&P500 52-week change 3 | 2.54% |
| 52-week high 3 | 376.72 |
| 52-week low 3 | 206.19 |
| 50-day moving average 3 | 352.67 |
| 200-day moving average 3 | 287.65 |
Share statistics
| Avg vol (3-month) 3 | 436.16k |
| Avg vol (10-day) 3 | 370.38k |
| Shares outstanding 5 | 74.24M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 73.84M |
| % held by insiders 1 | 0.53% |
| % held by institutions 1 | 95.06% |
| Shares short (14 May 2023) 4 | 863.76k |
| Short ratio (14 May 2023) 4 | 2 |
| Short % of float (14 May 2023) 4 | 1.52% |
| Short % of shares outstanding (14 May 2023) 4 | 1.16% |
| Shares short (prior month 13 Apr 2023) 4 | 1.35M |
Dividends & splits
| Forward annual dividend rate 4 | 0.76 |
| Forward annual dividend yield 4 | 0.22% |
| Trailing annual dividend rate 3 | 0.74 |
| Trailing annual dividend yield 3 | 0.22% |
| 5-year average dividend yield 4 | 0.32 |
| Payout ratio 4 | 10.15% |
| Dividend date 3 | 01 Aug 2023 |
| Ex-dividend date 4 | 24 Jul 2023 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 26 Sept 2013 |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Mar 2023 |
Profitability
| Profit margin | 19.15% |
| Operating margin (ttm) | 25.74% |
Management effectiveness
| Return on assets (ttm) | 13.22% |
| Return on equity (ttm) | 21.64% |
Income statement
| Revenue (ttm) | 2.88B |
| Revenue per share (ttm) | 38.74 |
| Quarterly revenue growth (yoy) | -0.50% |
| Gross profit (ttm) | 1.14B |
| EBITDA | 864.8M |
| Net income avi to common (ttm) | 552.1M |
| Diluted EPS (ttm) | 7.28 |
| Quarterly earnings growth (yoy) | -19.40% |
Balance sheet
| Total cash (mrq) | 886.3M |
| Total cash per share (mrq) | 11.94 |
| Total debt (mrq) | 314.4M |
| Total debt/equity (mrq) | 11.32 |
| Current ratio (mrq) | 3.62 |
| Book value per share (mrq) | 37.42 |
Cash flow statement
| Operating cash flow (ttm) | 710.9M |
| Levered free cash flow (ttm) | 264.94M |
© 2023 Yahoo. All rights reserved.